Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Thompson

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Human Gene Therapy|May 26, 1999
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trialJ R Herman, H L Adler, E Aguilar-Cordova, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2009
The role of caveolin-1 in prostate cancer: clinical implicationsT C Thompson, S A Tahir, L Li, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancerY Nasu, C H Bangma, G W Hull, et al.
The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.
Gene Therapy|August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic modelY Nasu, C H Bangma, G W Hull, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancerK Tabata, M Watanabe, K Naruishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastasesA M Stapleton, T L Timme, A E Gousse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Elevated expression of caveolin is associated with prostate and breast cancerG Yang, L D Truong, T L Timme, et al.
Cancer Gene Therapy|February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancerK Naruishi, T L Timme, N Kusaka, et al.
Clinical & Experimental Metastasis|July 27, 2001
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progressionM R Shaker, G Yang, T L Timme, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Human Gene Therapy|May 26, 1999
In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trialJ R Herman, H L Adler, E Aguilar-Cordova, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2009
The role of caveolin-1 in prostate cancer: clinical implicationsT C Thompson, S A Tahir, L Li, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancerY Nasu, C H Bangma, G W Hull, et al.
The Journal of Urology|May 8, 2000
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancerM Shalev, D Kadmon, B S Teh, et al.
Gene Therapy|August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic modelY Nasu, C H Bangma, G W Hull, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2008
Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancerK Tabata, M Watanabe, K Naruishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastasesA M Stapleton, T L Timme, A E Gousse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Elevated expression of caveolin is associated with prostate and breast cancerG Yang, L D Truong, T L Timme, et al.
Cancer Gene Therapy|February 18, 2006
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancerK Naruishi, T L Timme, N Kusaka, et al.
Clinical & Experimental Metastasis|July 27, 2001
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progressionM R Shaker, G Yang, T L Timme, et al.
Pageof 13